[HTML][HTML] miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis

CE Condrat, DC Thompson, MG Barbu, OL Bugnar… - Cells, 2020 - mdpi.com
MicroRNAs (miRNAs) represent a class of small, non-coding RNAs with the main roles of
regulating mRNA through its degradation and adjusting protein levels. In recent years …

[HTML][HTML] Pathogenic mechanisms associated with different clinical courses of multiple sclerosis

H Lassmann - Frontiers in immunology, 2019 - frontiersin.org
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS),
which may at later times transform into secondary progressive disease (SPMS). In a minority …

The potential of serum neurofilament as biomarker for multiple sclerosis

S Bittner, J Oh, EK Havrdová, M Tintoré, F Zipp - Brain, 2021 - academic.oup.com
Multiple sclerosis is a highly heterogeneous disease, and the detection of neuroaxonal
damage as well as its quantification is a critical step for patients. Blood-based serum …

[HTML][HTML] Exosomal microRNA signatures in multiple sclerosis reflect disease status

S Ebrahimkhani, F Vafaee, PE Young, SSJ Hur… - Scientific reports, 2017 - nature.com
Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central
nervous system (CNS). There is currently no single definitive test for MS. Circulating …

[HTML][HTML] Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure

M Lombardi, R Parolisi, F Scaroni, E Bonfanti… - Acta …, 2019 - Springer
Microglia are highly plastic immune cells which exist in a continuum of activation states. By
shaping the function of oligodendrocyte precursor cells (OPCs), the brain cells which …

Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years

E Cantó, C Barro, C Zhao, SJ Caillier… - JAMA …, 2019 - jamanetwork.com
Importance Blood sample–based biomarkers that are associated with clinically meaningful
outcomes for patients with multiple sclerosis (MS) have not been developed. Objective To …

Toward precision phenotyping of multiple sclerosis

D Pitt, CH Lo, SA Gauthier, RA Hickman… - Neurology …, 2022 - AAN Enterprises
The classification of multiple sclerosis (MS) has been established by Lublin in 1996 and
revised in 2013. The revision includes clinically isolated syndrome, relapsing-remitting …

The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets

R Hohlfeld, K Dornmair, E Meinl, H Wekerle - The Lancet Neurology, 2016 - thelancet.com
Identification of the target antigens of pathogenic antibodies and T cells is of fundamental
importance for understanding the pathogenesis of multiple sclerosis, and for the …

Biomarkers in multiple sclerosis

A Paul, M Comabella, R Gandhi - Cold Spring …, 2019 - perspectivesinmedicine.cshlp.org
Multiple sclerosis (MS) is a chronic neurodegenerative autoimmune disease with a complex
clinical course characterized by inflammation, demyelination, and axonal degeneration …

Neurodegenerative disorders of alzheimer, parkinsonism, amyotrophic lateral sclerosis and multiple sclerosis: an early diagnostic approach for precision treatment

N Pathak, SK Vimal, I Tandon, L Agrawal… - Metabolic Brain …, 2021 - Springer
Neurodegenerative diseases (NDs) are characterised by progressive dysfunction of
synapses, neurons, glial cells and their networks. Neurodegenerative diseases can be …